title: Biomarkers as intermediate end points in chemoprevention trials.
authors.affiliation: Department of Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
authors.forename: S M
authors.initials: SM
authors.lastname: Lippman
authors.forename: J S
authors.initials: JS
authors.lastname: Lee
authors.forename: R
authors.initials: R
authors.lastname: Lotan
authors.forename: W
authors.initials: W
authors.lastname: Hittelman
authors.forename: M J
authors.initials: MJ
authors.lastname: Wargovich
authors.forename: W K
authors.initials: WK
authors.lastname: Hong
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D002338:Carotenoids / Q000627:therapeutic use; D002454:Cell Differentiation; D002455:Cell Division; D002986:Clinical Trials as Topic / Q000379:methods; D004067:Digestive System Neoplasms / Q000517:prevention & control; D006801:Humans; D015162:Micronucleus Tests; D009369:Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000517:prevention & control*; D012142:Respiratory Tract Neoplasms / Q000517:prevention & control; D012176:Retinoids / Q000627:therapeutic use
chemical_list: D014408:Biomarkers, Tumor; D012176:Retinoids; D002338:Carotenoids